Explore
Trendline
Lucid Diagnostics Reports First Quarter 2026 Financial Results Highlighting Revenue Growth and Strategic Initiatives
Lucid Diagnostics Reports First Quarter 2026 Financial Results Highlighting Revenue Growth and Strategic Initiatives
Read More
Trendline
CytoSorbents Reports Increased Revenue Amidst Financial Losses in Q1 2026
CytoSorbents Reports Increased Revenue Amidst Financial Losses in Q1 2026
Read More
Trendline
Shoulder Innovations Reports Significant Revenue Growth and Raises 2026 Outlook
Shoulder Innovations Reports Significant Revenue Growth and Raises 2026 Outlook
Read More
Trendline
Stampede Drilling Inc. Reports Increased Utilization and Revenue in Q1 2026
Stampede Drilling Inc. Reports Increased Utilization and Revenue in Q1 2026
Read More
Trendline
Healthy Extracts Reports 73% Revenue Increase in Q1 2026, Driven by Strategic Partnerships
Healthy Extracts Reports 73% Revenue Increase in Q1 2026, Driven by Strategic Partnerships
Read More
Trendline
Anteris Technologies Reports Q1 2026 Financial Results with Revenue Decline
Anteris Technologies Reports Q1 2026 Financial Results with Revenue Decline
Read More
Trendline
Anteris Technologies Reports Q1 2026 Financial Results with Increased Net Loss
Anteris Technologies Reports Q1 2026 Financial Results with Increased Net Loss
Read More
Trendline
Crescita Reports Increased Revenue and Gross Profit in Q1 2026
Crescita Reports Increased Revenue and Gross Profit in Q1 2026
Read More
Trendline
Veracyte Reports Strong Q1 Earnings, Boosting Stock by 23%
Veracyte Reports Strong Q1 Earnings, Boosting Stock by 23%
Read More
Trendline
Curis Reports Q1 2026 Financial Results and Advances Cancer Drug Trials
Curis Reports Q1 2026 Financial Results and Advances Cancer Drug Trials
Read More
Trendline
Omeros Corporation to Release First Quarter 2026 Financial Results and Host Conference Call
Omeros Corporation to Release First Quarter 2026 Financial Results and Host Conference Call
Read More
Trendline
AN2 Therapeutics Reports Q1 2026 Financial Results and Pipeline Updates
AN2 Therapeutics Reports Q1 2026 Financial Results and Pipeline Updates
Read More